title: Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.
abstract: Human pluripotent stem cell (hPSC)-derived cell therapy requires production of therapeutic cells in large quantity, which starts from thawing the cryopreserved cells from a working cell bank or a master cell bank. An optimal cryopreservation and thaw process determines the efficiency of hPSC expansion and plays a significant role in the subsequent lineage-specific differentiation. However, cryopreservation in hPSC bioprocessing has been a challenge due to the unique growth requirements of hPSC, the sensitivity to cryoinjury, and the unscalable cryopreservation procedures commonly used in the laboratory. Tremendous progress has been made to identify the regulatory pathways regulating hPSC responses during cryopreservation and the development of small molecule interventions that effectively improves the efficiency of cryopreservation. The adaption of these methods in current good manufacturing practices (cGMP)-compliant cryopreservation processes not only improves cell survival, but also their therapeutic potency. This review summarizes the advances in these areas and discusses the technical requirements in the development of cGMP-compliant hPSC cryopreservation process.
authors.affiliation: Department of Chemical and Biomedical Engineering, Florida State University , Tallahassee, Florida.
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Teng
authors.initials: T
authors.lastname: Ma
keywords: cell banking; cryopreservation; human pluripotent stem cell